Home » Newsletters » BioWorld Science

BioWorld Science

June 13, 1997

View Archived Issues

Inex: Q1 1997 highlights

ACE inhibitors for diabetes

GLP-1 and analogues studied for diabetes

rIGF-1 + insulin improves metabolic control in IDDM patients

Fibrinogen antagonists in IDDM

Results of D1/D2 receptor coactivation in diabetes

Favorable preclinical results with REPEL-CV for cardiovascular surgery

Combination insulin sensitizer + alpha-glucosidase inhibitor for diabetes

Carvedilol and its metabolite attenuate Hb-mediated neuronal injury

Gensia receives FDA approval of ANDA for atracurium besilate

KW-3902 may be beneficial in hemorrhagic shock

Testosterone transdermal patch now available in the U.S. in a once-daily formulation

Melatonin evaluated in emergency physicians on the night shift

D-0870 for AIDS-related oral candidiasis

Guilford granted U.S. patent for polymer drug delivery of anticancer agents

Activity of Sch-48973 against enteroviruses

AM-1155: in vitro and in vivo antichlamydial activity

Bay-12-8039: time-kill and PAE studies

Oral human immunoglobulin enters clinic for severe RA

IND for gene therapy for cystic fibrosis approved

Osiris and Activated Cell Therapy initiate MSC collaboration

Highlights from the 12th Annual ASH Scientific Meeting

Schering-Plough and Corvas sign hepatitis research collaboration

Neurogen reports promising phase I results with antiobesity drug

Banyu to shift development from NB-506 to new indolocarbazole

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...